Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778258 · ClinicalTrials.gov registry record · Phase 2
Study of Milk Allergy and Tolerance in Children
A Phase 2 study of Food Hypersensitivity and Milk Hypersensitivity, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT00778258 is a Phase 2 study of Food Hypersensitivity and Milk Hypersensitivity that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 170 participants, below the 4,629-participant average among 5 other Food Hypersensitivity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00778258, a Phase 2 study of Food Hypersensitivity and Milk Hypersensitivity, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if children who are allergic to milk can increase tolerance through frequent dose-escalation every 6 months versus 12 months leading to eventual tolerance of less heated milk and ultimately unheated milk.
Conditions Studied
Interventions
- BIOLOGICAL Baked Milk
- BIOLOGICAL Non-baked Milk
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00778258
The ClinicalTrials.gov registry entry for NCT00778258 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,629-participant average among 5 other Food Hypersensitivity trials with a reported enrollment target (96% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Food Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which Baked Milk is the first listed.
NCT00778258 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00778258 about?
NCT00778258 is a clinical study titled "Study of Milk Allergy and Tolerance in Children". The purpose of this study is to determine if children who are allergic to milk can increase tolerance through frequent dose-escalation every 6 months versus 12 months leading to eventual tolerance of less heated milk and ultimately unheated milk.
What is the current status of trial NCT00778258?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2008-08. Estimated completion is 2014-11.
What conditions does trial NCT00778258 study?
This clinical trial studies the following conditions: Food Hypersensitivity, Milk Hypersensitivity.
What interventions are being tested in trial NCT00778258?
The interventions under investigation include: Baked Milk (BIOLOGICAL), Non-baked Milk (BIOLOGICAL).
Who is sponsoring clinical trial NCT00778258?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00778258 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
RECRUITING · Phase 2
-
A Study of Sublingual Immunotherapy in Peanut-allergic Children
COMPLETED · Phase 2
-
A Registry for the Food Allergy Community
RECRUITING
-
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
RECRUITING · Phase 1
-
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.